合并间质性肺病的肿瘤相关肌炎临床特征:大规模多中心队列研究
该多中心队列纳入497例PM/DM相关ILD患者,CAM定义为PM/DM诊断前后3年内确诊恶性肿瘤,发生率为6.4%。CAM患者年龄更大、关节炎更少、血清KL-6更低,生存更差,主要归因于合并恶性肿瘤的额外死亡,而ILD相关呼吸衰竭死亡率两组相似。
要点
- PM/DM相关ILD患者中CAM发生率为6.4%,需警惕合并恶性肿瘤。
- 年龄较大、无关节炎、血清KL-6较低是合并恶性肿瘤的预测因素。
- CAM患者生存更差,超额死亡主要来自恶性肿瘤而非ILD呼吸衰竭。
核心结论
- PM/DM相关ILD患者可合并恶性肿瘤,且显著影响死亡率。
研究设计与样本
- 多中心回顾性与前瞻性新发队列,纳入497例PM/DM相关ILD患者。
- CAM定义为PM/DM诊断前3年内或诊断后3年内确诊恶性肿瘤。
主要发现
- 497例中32例(6.4%)识别为CAM。
- CAM患者年龄更大(64 vs 55岁,P < 0.001)。
- CAM患者关节炎发生率更低(24% vs 49%,P = 0.01)。
- CAM患者血清KL-6水平更低(687 vs 820 IU/l,P = 0.03)。
- CAM患者生存更差(P = 0.006),ILD相关呼吸衰竭死亡率两组相似(P = 0.51)。
关键数值与推荐
- 肌炎特异性自身抗体分布(包括抗MDA5、抗氨基酰tRNA合成酶、抗TIF1-γ抗体)在两组间无差异。
临床怎么用
- 对PM/DM相关ILD患者,尤其年龄较大、无关节炎、血清KL-6较低者,应警惕合并恶性肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify the incidence, risk factors, and impact of malignancy in patients with PM/DM-associated interstitial lung disease (ILD). METHODS: This study used data from 497 patients with PM/DM-associated ILD enrolled in a multicentre, retrospective and prospective cohort of incident cases. Cancer-associated myositis (CAM) was defined as malignancy diagnosed within 3 years before or after PM/DM diagnosis. Demographic and clinical information was recorded at the time of diagnosis, and data about the occurrence of mortality and malignancy was collected. RESULTS: CAM was identified in 32 patients with PM/DM-associated ILD (6.4%). Patients with CAM were older (64 vs 55 years, P < 0.001), presented with arthritis less frequently (24% vs 49%, P = 0.01), and showed a lower level of serum Krebs von den Lungen-6 (687 vs 820 IU/l, P = 0.03) than those without CAM. The distribution of myositis-specific autoantibodies, including anti-melanoma differentiation-associated gene 5, anti-aminoacyl tRNA synthetase, and anti-transcriptional intermediary factor 1-γ antibodies, did not differ between the groups. Survival analysis demonstrated that CAM patients had a poorer survival than non-CAM patients (P = 0.006), primarily due to excess deaths by concomitant malignancy, while mortality due to ILD-related respiratory failure was similar between the groups (P = 0.51). CONCLUSION: Concomitant malignancy can occur in patients with PM/DM-associated ILD, and has significant impact on mortality. Older age, lack of arthritis, and a lower level of serum Krebs von den Lungen-6 at diagnosis are predictors of concomitant malignancy.
引用
- Kaneko Y, Nunokawa T, Taniguchi Y, et al. Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study. Rheumatology (Oxford). 2020. PMID: 31382295. doi:10.1093/rheumatology/kez238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。